Brand Name | Status | Last Update |
---|---|---|
ctx3 rinse | OTC monograph final | 2022-12-31 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 6 | 14 | 22 | 1 | — | 43 |
Lymphoma | D008223 | — | C85.9 | 7 | 19 | 12 | 1 | 2 | 37 |
Leukemia | D007938 | — | C95 | 3 | 7 | 8 | 2 | 1 | 20 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | 6 | 8 | 2 | 1 | 18 |
Lymphoid leukemia | D007945 | — | C91 | 1 | 6 | 8 | 2 | 1 | 18 |
Follicular lymphoma | D008224 | — | C82 | 2 | 3 | 3 | 1 | — | 8 |
Osteoporosis | D010024 | EFO_0003882 | M81.0 | — | — | — | 1 | 1 | 2 |
Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 3 | 8 | 8 | — | 2 | 19 |
B-cell lymphoma | D016393 | — | — | 5 | 7 | 7 | — | 2 | 17 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 5 | 7 | 4 | — | 1 | 15 |
Triple negative breast neoplasms | D064726 | — | — | 3 | 5 | 3 | — | — | 11 |
Inflammatory breast neoplasms | D058922 | — | — | 1 | — | 3 | — | — | 4 |
Lupus nephritis | D008181 | EFO_0005761 | — | — | — | 4 | — | — | 4 |
Nephritis | D009393 | — | N05 | — | — | 4 | — | — | 4 |
Colorectal neoplasms | D015179 | — | — | — | — | 1 | — | 1 | 2 |
Mucinous adenocarcinoma | D002288 | — | — | — | — | 2 | — | — | 2 |
Ductal carcinoma breast | D018270 | — | — | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuroblastoma | D009447 | EFO_0000621 | — | 2 | 2 | — | — | — | 3 |
Myeloid leukemia acute | D015470 | — | C92.0 | 2 | 1 | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | 2 | 1 | — | — | — | 2 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 2 | 1 | — | — | — | 2 |
Mantle-cell lymphoma | D020522 | — | C83.1 | — | 2 | — | — | — | 2 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | — | 2 |
Central nervous system neoplasms | D016543 | — | — | — | 2 | — | — | — | 2 |
Sarcoma | D012509 | — | — | — | 1 | — | — | — | 1 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 1 | — | — | — | 1 |
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Endometrial neoplasms | D016889 | EFO_0004230 | — | 1 | — | — | — | — | 1 |
Uterine cervical neoplasms | D002583 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Lornoxicam |
INN | lornoxicam |
Description | Lornoxicam, also known as chlortenoxicam, is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory and antipyretic (fever reducing) properties. It is available in oral and parenteral formulations.
|
Classification | Small molecule |
Drug class | anti-inflammatory agents (isoxicam type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O |
PDB | — |
CAS-ID | 70374-39-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1569487 |
ChEBI ID | 31783 |
PubChem CID | 5282204 |
DrugBank | DB06725 |
UNII ID | ER09126G7A (ChemIDplus, GSRS) |